Cargando…
Statin use and incident cardiovascular events in renal transplant recipients
BACKGROUND: Statins achieve potent LDL lowering in the general population leading to a significant cardiovascular (CV) risk reduction. In renal transplant recipients (RTR) statins are included in treatment guidelines, however, conclusive evidence of improved cardiovascular outcomes has not been unif...
Autores principales: | Anderson, Josephine L. C., van der Giet, Markus, Gomes Neto, Antonio W., Bakker, Stephan J. L., Tietge, Uwe J. F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596424/ https://www.ncbi.nlm.nih.gov/pubmed/34042174 http://dx.doi.org/10.1111/eci.13594 |
Ejemplares similares
-
Autoantibodies to Apolipoprotein A-1 as Independent Predictors of Cardiovascular Mortality in Renal Transplant Recipients
por: Anderson, Josephine L.C., et al.
Publicado: (2019) -
The Framingham Risk Score Is Associated with Chronic Graft Failure in Renal Transplant Recipients
por: Anderson, Josephine L. C., et al.
Publicado: (2021) -
Remnant lipoprotein cholesterol is associated with incident new onset diabetes after transplantation (NODAT) in renal transplant recipients: results of the TransplantLines Biobank and cohort Studies
por: Szili-Torok, Tamas, et al.
Publicado: (2022) -
Group IIA Secretory Phospholipase A(2) Predicts Graft Failure and Mortality in Renal Transplant Recipients by Mediating Decreased Kidney Function
por: Annema, Wijtske, et al.
Publicado: (2020) -
Physical Activity and the Development of Post-Transplant Diabetes Mellitus, and Cardiovascular- and All-Cause Mortality in Renal Transplant Recipients
por: Byambasukh, Oyuntugs, et al.
Publicado: (2020)